Validation of CTS5 model in large-scale breast cancer population and the impact of menopausal and HER2 status on its prognostic value

Clinical Treatment Score post-5 years (CTS5) is a promising prognostic tool to evaluate late recurrence risk for breast cancer. Our study aimed to validate its prognostic value in large-scale population and explore the impact of menopausal and HER2 status on CTS5 model. We performed a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Changjun, Chen, Chang, Lin, Yan, Zhou, Yidong, Mao, Feng, Zhu, Hanjiang, Zhang, Xiaohui, Shen, Songjie, Huang, Xin, Wang, Xuefei, Zhao, Bin, Yang, Jing, Sun, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070010/
https://www.ncbi.nlm.nih.gov/pubmed/32170181
http://dx.doi.org/10.1038/s41598-020-61648-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7070010/
https://www.ncbi.nlm.nih.gov/pubmed/32170181
http://dx.doi.org/10.1038/s41598-020-61648-1

Ejemplares similares